Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Akorn Inc (AKRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,974,098
  • Shares Outstanding, K 125,260
  • Annual Sales, $ 841,050 K
  • Annual Income, $ -24,550 K
  • 36-Month Beta 1.71
  • Price/Sales 2.39
  • Price/Cash Flow 29.30
  • Price/Book 2.38

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.42 +19.45%
on 05/24/18
16.25 -1.35%
on 06/20/18
+2.30 (+16.75%)
since 05/22/18
3-Month
10.76 +49.05%
on 05/03/18
19.81 -19.08%
on 04/20/18
-2.49 (-13.44%)
since 03/22/18
52-Week
10.76 +49.05%
on 05/03/18
33.73 -52.48%
on 07/17/17
-17.50 (-52.19%)
since 06/22/17

Most Recent Stories

More News
Aerie Pharmaceut is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (AERI , AKRX , SUPN , ZTS , MRK )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

AERI : 70.45 (+4.60%)
SUPN : 57.05 (-2.23%)
AKRX : 16.03 (+1.71%)
51.8% Return Seen to Date on SmarTrend Akorn Inc Call (AKRX)

SmarTrend identified a Downtrend for Akorn Inc (NASDAQ:AKRX) on February 23rd, 2018 at $30.24. In approximately 4 months, Akorn Inc has returned 51.81% as of today's recent price of $14.57.

AKRX : 16.03 (+1.71%)
Notable Friday Option Activity: AKRX, VICR, ICPT

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Akorn Inc , where a total volume of 14,292 contracts has been traded thus far today,...

AKRX : 16.03 (+1.71%)
Akorn Inc Has Returned 53.9% Since SmarTrend Recommendation (AKRX)

SmarTrend identified a Downtrend for Akorn Inc (NASDAQ:AKRX) on February 23rd, 2018 at $30.24. In approximately 3 months, Akorn Inc has returned 53.89% as of today's recent price of $13.94.

AKRX : 16.03 (+1.71%)
Lawsuit for Investors in shares of Akorn, Inc. (NASDAQ: AKRX) announced by Shareholders Foundation

The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Akorn, Inc. (NASDAQ: AKRX) shares.

AKRX : 16.03 (+1.71%)
Options Traders Expect Huge Moves in Akorn (AKRX) Stock

Investors in Akorn (AKRX) need to pay close attention to the stock based on moves in the options market lately.

AKRX : 16.03 (+1.71%)
Moore Kuehn, PLLC Announces an Investigation Involving Possible Breaches of Fiduciary Duties by Officers and Directors of Akorn, Inc.

Moore Kuehn, PLLC is investigating potential claims for breach of fiduciary duty involving the directors and officers of Akorn, Inc. (NASDAQ: AKRX). On February 26, 2018 Fresenius SE & Co. KGaA ("Fresenius")...

FSNUF : 80.5000 (-0.30%)
AKRX : 16.03 (+1.71%)
Akorn Inc Shares Down 53.5% Since SmarTrend's Sell Call (AKRX)

SmarTrend identified a Downtrend for Akorn Inc (NASDAQ:AKRX) on February 23rd, 2018 at $30.24. In approximately 3 months, Akorn Inc has returned 53.46% as of today's recent price of $14.07.

AKRX : 16.03 (+1.71%)
DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Akorn, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 7, 2018 - AKRX

NEW YORK, NY / ACCESSWIRE / May 7, 2018 / The following statement is being issued by Levi & Korsinsky, LLP:

AKRX : 16.03 (+1.71%)
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Akorn, Inc. and Reminds Investors With Losses In Excess of $50,000 to Contact The Firm

LOS ANGELES, CA / ACCESSWIRE / May 7, 2018 / , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akorn, Inc. ("Akorn" or the "Company") (NASDAQ: ) for...

AKRX : 16.03 (+1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AKRX with:

Business Summary

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals,...

See More

Key Turning Points

2nd Resistance Point 16.43
1st Resistance Point 16.23
Last Price 16.03
1st Support Level 15.65
2nd Support Level 15.27

See More

52-Week High 33.73
Fibonacci 61.8% 24.95
Fibonacci 50% 22.24
Fibonacci 38.2% 19.53
Last Price 16.03
52-Week Low 10.76

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar